Lisata Therapeutics Inc (LSTA) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of significant trading trends, neutral insider and hedge fund sentiment, poor financial performance, and absence of positive news or catalysts make it a stock to hold off on for now.
The MACD histogram is negative (-0.101) and contracting, indicating bearish momentum. RSI is neutral at 37.155, and moving averages are converging, showing no clear trend. Key support is at 4.109, and resistance is at 4.498. The stock has an 80% chance to increase 0.06% in the next day and 10.81% in the next month, but these are not compelling enough for a buy signal.
NULL. No recent news or significant trading trends. Gross margin remains at 100%, but this is offset by poor overall financial performance.
No significant insider or hedge fund activity. Lack of valuation data and no recent congress trading activity.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$4,249,000 (-13.81% YoY), and EPS fell to -0.49 (-16.95% YoY). Gross margin remained at 100%, but this does not offset the negative income and EPS trends.
No analyst rating or price target changes available for this stock.